Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kangfuxin liquid for diabetic peripheral neuropathy
ChiCTR2400080860Phase 4Not yet recruiting
- Sponsor
- Beijing Hospital
- Start
- Feb 2024
- Countries
- 1
01
Overview
Phase 4, randomised trial in diabetic polyneuropathy (DPN) comparing Kangfuxin liquid group with Placebo group (2 arms). Primary endpoint: Nerve conduction velocity. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
kangfuxin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on ChiCTR2400080860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080860.